Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2600117749Phase 4Not yet recruiting
Phase 4, randomised trial in perioperative neurocognitive disorder and postoperative delirium (POD) comparing Cipropofol + remifentanil with Propofol + remifentanil (2 arms). Primary endpoints: Postoperative delirium incidence rate and Incidence of delayed early postoperative neurocognitive recovery. Planned start Jan 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2600117749.